{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:03:04Z","timestamp":1788951784218,"version":"build-2803163510"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Platinum-based first-line chemotherapy for small lung cancers has been a mainstream therapy for the past several decades. However, its efficacy has been suboptimal, and the research is now focused on improving the treatment and prognosis of competitive nutrition and multidrug combination techniques. Small cell lung cancer (SCLC) is not only affected by smoking, age, sex and other external factors, but also the tumor micro-environment and the nutritional status of patients themselves are of great significance for the prevention and treatment of SCLC, a malignant tumor. According to past research, malnutrition is related to the intolerance to immunotherapy, decline in quality of life, psychological disturbances, and low survival rates and prognosis. Numerous studies have shown that a low Prognostic Nutritional Index (PNI) serves as an independent prognostic factor linked to reduced overall survival across various cancer types. Additionally, PNI has been associated with disease-free survival and progression-free survival in certain cancers, such as lung cancer (LC). Recent research has indicated that the PNI can serve as an independent predictor of both long-term outcomes and short-term complications in SCLC patients. However, a systematic consensus on this matter has yet to be established. This paper focuses on the role and influence of PNI in the immunotherapy of SCLC, and proposes the possibility of dietary therapy for SCLC patients under the guidance of PNI. Finally, the authors pointed out that PNI will become a new strategy for comprehensive immunotherapy of SCLC.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1560241","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T05:16:54Z","timestamp":1748236614000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Immunotherapy of small cell lung cancer based on prognostic nutritional index"],"prefix":"10.3389","volume":"16","author":[{"given":"Xinling","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040820","article-title":"Pathology and classification of SCLC","volume":"13","author":"Raso","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v129.22","article-title":"Advancing immunotherapy in small cell lung cancer","volume":"129","author":"Carlisle","year":"2023","journal-title":"Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistic","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.07.018","article-title":"Overcoming chemotherapy resistance in SCLC","volume":"16","author":"Herzog","year":"2021","journal-title":"J Thorac Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009667","article-title":"New developments in immunotherapy for SCLC","volume":"13","author":"Dolkar","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1759-7714.15178","article-title":"Advances in new targets for immunotherapy of small cell lung cancer","volume":"15","author":"Zheng","year":"2024","journal-title":"Thorac Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(80)90246-9","article-title":"Prognostic nutritional index in gastrointestinal surgery","volume":"139","author":"Buzby","year":"1980","journal-title":"Am J Surg"},{"key":"B9","article-title":"Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients","volume":"85","author":"Onodera","year":"1984","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1219929","article-title":"Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1365-277X.2010.01058.x","article-title":"Nutritional status, nutrition practices and post-operative complications in patients with gastrointestinal cancer","volume":"23","author":"Garth","year":"2010","journal-title":"J Hum Nutr Diet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(01)00558-5","article-title":"Clinical pictures of malnutrition in ill elderly subjects","volume":"17","author":"Seiler","year":"2001","journal-title":"Nutrition"},{"key":"B13","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3390\/nu14040910","article-title":"Malnutrition in hospitalized old patients: screening and diagnosis, clinical outcomes, and management","volume":"14","author":"Bellanti","year":"2022","journal-title":"Nutrients"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-009-4065-y","article-title":"Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma","volume":"40","author":"Nozoe","year":"2010","journal-title":"Surg Today"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2251573","DOI":"10.1080\/13685538.2023.2251573","article-title":"Survival outcomes and prognostic nutritional index in very elderly small-cell lung cancer patients: importance of active treatment and nutritional support","volume":"26","author":"Almuradova","year":"2023","journal-title":"Aging Male"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.03.009","article-title":"Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC","volume":"86","author":"Niu","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.21873\/cdp.10021","article-title":"Improved chemotherapy outcomes of patients with small-cell lung cancer treated with combined alkalization therapy and intravenous vitamin C","volume":"1","author":"Hamaguchi","year":"2021","journal-title":"Cancer Diagn Progn"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e52720","DOI":"10.7759\/cureus.52720","article-title":"Prognostic role of pretreatment prognostic nutritional index in advanced lung cancer patients receiving first-line immunotherapy: A meta-analysis","volume":"16","author":"Yang","year":"2024","journal-title":"Cureus"},{"key":"B19","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.3747\/co.27.5183","article-title":"Immuno-oncology-the new paradigm of lung cancer treatment","volume":"27","author":"Dawe","year":"2020","journal-title":"Curr Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2174\/1871520621666211119085834","article-title":"Gallic acid: A dietary polyphenol that exhibits anti-neoplastic activities by modulating multiple oncogenic targets","volume":"22","author":"Tuli","year":"2022","journal-title":"Anticancer Agents Med Chem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.809308","article-title":"Cancer chemoprevention: A strategic approach using phytochemicals","volume":"12","author":"Mohan Shankar","year":"2021","journal-title":"Front Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/cancers14030457","article-title":"c-Myc targets HDAC3 to suppress NKG2DL expression and innate immune response in N-type SCLC through histone deacetylation","volume":"14","author":"Zhao","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.71","article-title":"Unravelling the biology of SCLC: implications for therapy","volume":"14","author":"Sabari","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1378\/chest.106.6_Supplement.320S","article-title":"A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy","volume":"106","author":"Lad","year":"1994","journal-title":"Chest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21785","article-title":"Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions","volume":"73","author":"Megyesfalvi","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e21840","DOI":"10.1097\/MD.0000000000021840","article-title":"Prognostic significance of preoperative prognostic nutritional index in ovarian cancer: A systematic review and meta-analysis","volume":"99","author":"Dai","year":"2020","journal-title":"Med (Baltimore)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-20-1739","article-title":"The prognostic value of pretreatment prognostic nutritional index in patients with small cell lung cancer and it\u2019s influencing factors: a meta-analysis of observational studies","volume":"12","author":"Jiang","year":"2020","journal-title":"J Thorac Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.21037\/apm-21-2740","article-title":"Correlation of the controlling nutritional status score and the prognostic nutritional index with the prognosis of patients treated with radiotherapy for small-cell lung cancer","volume":"10","author":"Li","year":"2021","journal-title":"Ann Palliat Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"292","DOI":"10.21037\/tlcr-23-696","article-title":"Systemic immune index predicts tumor-infiltrating lymphocyte intensity and immunotherapy response in small cell lung cancer","volume":"13","author":"Deng","year":"2024","journal-title":"Transl Lung Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1211752","article-title":"Common nutritional\/inflammatory indicators are not effective tools in predicting the overall survival of patients with small cell lung cancer undergoing first-line chemotherapy","volume":"13","author":"Tian","year":"2023","journal-title":"Front Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","article-title":"Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities","volume":"39","author":"Gay","year":"2021","journal-title":"Cancer Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.21037\/atm-21-4528","article-title":"Long-term and short-term prognostic value of the prognostic nutritional index in cancer: a narrative review","volume":"9","author":"Yan","year":"2021","journal-title":"Ann Transl Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"630","DOI":"10.21037\/atm-19-4476","article-title":"Preoperative systemic immune-inflammation index and prognostic nutritional index predict prognosis of patients with pulmonary neuroendocrine tumors after surgical resection","volume":"8","author":"He","year":"2020","journal-title":"Ann Transl Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2848220","DOI":"10.1155\/2022\/2848220","article-title":"Efficacy and safety of PD-1\/PD-L1 inhibitor chemotherapy combined with lung cancer fang no. 1 in relapsed and refractory SCLC: A retrospective observational study","volume":"2022","author":"Wang","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1186\/s12885-021-08519-8","article-title":"Beta-hydroxy beta-methylbutyrate\/arginine\/glutamine (HMB\/Arg\/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH)","volume":"21","author":"Pascoe","year":"2021","journal-title":"BMC Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/cells9061376","article-title":"PD-1: its discovery, involvement in cancer immunotherapy, and beyond","volume":"9","author":"Ishida","year":"2020","journal-title":"Cells"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S252031","article-title":"Expression of PD-1 and PD-L1 on tumor-infiltrating lymphocytes predicts prognosis in patients with small-cell lung cancer","volume":"13","author":"Sun","year":"2020","journal-title":"Onco Targets Ther"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd2712","article-title":"Revisiting the PD-1 pathway","volume":"6","author":"Patsoukis","year":"2020","journal-title":"Sci Adv"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-014-0164-8","article-title":"Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014","volume":"5","author":"von Haehling","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"10481","DOI":"10.1038\/srep10481","article-title":"Ratio of C-reactive protein\/albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer","volume":"5","author":"Zhou","year":"2015","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jpen.v45.S2","article-title":"Nutrition challenges of cancer cachexia","volume":"45","author":"Gaafer","year":"2021","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"B47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semcdb.2016.02.009","article-title":"STAT3 in the systemic inflammation of cancer cachexia","volume":"54","author":"Zimmers","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nrc928","article-title":"New aspects of natural-killer-cell surveillance and therapy of cancer","volume":"2","author":"Smyth","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/tca.2018.9.issue-11","article-title":"Low pre-treatment nutritional index is significantly related to poor outcomes in small cell lung cancer","volume":"9","author":"Go","year":"2018","journal-title":"Thorac Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-20-755","article-title":"Pretreatment prognostic nutritional index is a prognostic marker for extensive-stage small cell lung cancer patients treated with anlotinib","volume":"12","author":"Liu","year":"2020","journal-title":"J Thorac Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201907_18439","article-title":"BLACAT1 is negatively associated with prognosis in patients with NSCLC and inhibits cell progression, metastasis and epithelial-mesenchymal transition through down-regulating Wnt\/\u03b2-catenin signaling pathway","volume":"23","author":"Xu","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1177\/1724600818799876","article-title":"Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: A systematic review and meta-analysis","volume":"33","author":"Hu","year":"2018","journal-title":"Int J Biol Markers"},{"key":"B53","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/SLA.0000000000002985","article-title":"Prognostic nutritional index, tumor-infiltrating lymphocytes, and prognosis in patients with esophageal cancer","volume":"271","author":"Okadome","year":"2020","journal-title":"Ann Surg"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.12781","article-title":"Preoperative prognostic nutritional index predicts long-term outcome in gastric cancer: A propensity score-matched analysis","volume":"38","author":"Hirahara","year":"2018","journal-title":"Anticancer Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3390\/biology10111200","article-title":"Identification of prognostic gene biomarkers in non-small cell lung cancer progression by integrated bioinformatics analysis","volume":"10","author":"Giannos","year":"2021","journal-title":"Biol (Basel)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2019.03.006","article-title":"Application of PD-1 blockade in cancer immunotherapy","volume":"17","author":"Wu","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1038\/s41598-018-21061-1","article-title":"Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC)","volume":"8","author":"Chae","year":"2018","journal-title":"Sci Rep"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S164968","article-title":"Non-small cell lung cancer leptomeningeal metastases treated with intrathecal therapy plus osimertinib and temozolomide and whole-brain radiation therapy: a case report","volume":"11","author":"Wang","year":"2018","journal-title":"Onco Targets Ther"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18073700","article-title":"Mediterranean Diet Implementation to Protect against Advanced Lung Cancer Index (ALI) Rise: Study Design and Preliminary Results of a Randomised Controlled Trial","volume":"18","author":"Gioxari","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12931-018-0785-0","article-title":"Pollution and respiratory disease: can diet or supplements help? A review","volume":"19","author":"Whyand","year":"2018","journal-title":"Respir Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1560241\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T05:16:55Z","timestamp":1748236615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1560241\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2025.1560241"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1560241","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"article-number":"1560241"}}